December 28, 2012
SHENZHEN, China and MOUNTAIN VIEW, Calif., -- BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the Committee on Foreign Investment in the United States ("CFIUS") regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, [...]
December 27, 2012
SUNNYVALE, Calif., -- Cepheid (NASDAQ: CPHD) today announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® CT/NG. Running on Cepheid's GeneXpert® Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). For the [...]
EMSL Expands Materials Testing Laboratory Capabilities
December 27, 2012
EMSL announced today the addition of Q600 SDT Simultaneous DSC-TGA, high-resolution Discovery TGA, and modulated DSC, all provided by TA Instruments. Thermal analysis includes the methods for measuring a certain parameter during the heating of a sample. Differential scanning calorimetry (DSC) where the parameter is heat flow into and out of the sample and thermo-gravimetry [...]
December 27, 2012
SAN DIEGO, -- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML). Trovagene holds an exclusive worldwide license to U.S. patent 8,222,370 and the [...]
BD Completes Acquisition of Safety Syringes, Inc.
December 26, 2012
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has completed its acquisition of Safety Syringes, Inc., a privately held California-based company that specializes in the development of anti-needlestick devices for prefilled syringes. The financial terms were not disclosed. The acquisition broadens BD’s [...]
Integrating matrix into 3D spheroid culture enables high throughput measurement of cell invasion
December 21, 2012
AMSBIO has announced the launch of the 3D Culture 96-Well BME* Cell Invasion Assay to address the growing need for more complete and physiologically predictive cancer invasion models. Invasive migration is a fundamental function underlying cellular processes such as angiogenesis, embryonic development, immune response, metastasis, and invasion of cancer cells. AMSBIO's new 3D Culture 96-Well [...]
December 21, 2012
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche’s portfolio of next-generation sequencing platforms. It is intended to support Roche’s GS Junior and GS FLX+ systems as well as the sequencing [...]
December 21, 2012
TST. LOUIS, -- SAFC Hitech Ltd., a wholly-owned subsidiary of Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, has signed an agreement to create a 50/50 joint venture (JV) with Korean-based Soulbrain Co. Ltd. ("Soulbrain"). Soulbrain is a publicly traded (KOSDAQ: 036830) specialty chemical company serving the flat panel display, semiconductor [...]
Dako acquires important IP rights in connectivity from System Dynamics
December 21, 2012
Dako, an Agilent Technologies company, has signed an agreement to acquire the intellectual property rights behind connectivity software from California-based software development company System Dynamics, Inc. (SDI). The SDI development team joins Dako and brings new software development competencies to one of the world’s leaders in cancer diagnostics. “The acquisition of the intellectual property rights [...]
December 21, 2012
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Corning, Inc.’s proposed acquisition of Becton, Dickinson and Company’s Discovery Labware Division would have been anticompetitive in the North American markets for tissue culture treated (TCT) multi-well plates, dishes, and flasks used in cell culture applications. Under the [...]

